Loading
Radiation oncologist who established stereotactic radiotherapy as a non-surgical option for primary kidney cancer.
Shankar Siva led the FASTRACK trials and the International Radiosurgery Oncology Consortium for Kidney pooled analyses showing stereotactic ablative body radiotherapy achieves near-complete local control of primary renal cell carcinoma in patients unfit for surgery, and leads TROG trials of SABR in oligometastatic prostate and lung cancer and of radiotherapy-immunotherapy combinations. He chairs the TROG genitourinary group.
Shares SBRT / SABR (stereotactic radiotherapy) and the tags radiotherapy, sbrt.
Shares SBRT / SABR (stereotactic radiotherapy) and the tags radiotherapy, sbrt.
Shares TROG Cancer Research and the tag radiotherapy.
Shares SBRT / SABR (stereotactic radiotherapy) and the tags radiotherapy, sbrt.
Shares TROG Cancer Research and the tag radiotherapy.
Shares Peter MacCallum Cancer Centre and the tag australia.
Shares Peter MacCallum Cancer Centre and the tag australia.